Vimarsana
Biggest News Aggregation in the World

Page 8 - Protein Engineering News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Protein Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Protein Engineering Today - Breaking & Trending Today

Llama nanobodies could be used to develop COVID-19 treatment - study - Vimarsana News

Llama nanobodies could be used to develop COVID-19 treatment - study

The study found that nanobodies derived from a llama could be used to develop an inhalable spray to combat COVID-19 and other viral diseases.

Source: jpost.com
HKUMed researchers discover more efficient CRISPR-Cas9 variants for gene therapy applications - Vimarsana News

HKUMed researchers discover more efficient CRISPR-Cas9 variants for gene therapy applications

A research team from the LKS Faculty of Medicine, The University of Hong Kong discovered more efficient CRISPR-Cas9 variants that could be useful for gene therapy applications.

Immune particles from llama blood could offer protection against several COVID-19 variants - Vimarsana News

Immune particles from llama blood could offer protection against several COVID-19 variants

Mount Sinai-led researchers have shown that tiny, robust immune particles derived from the blood of a llama could provide strong protection against every COVID-19 variant, including Omicron, and 18 similar viruses including SARS-CoV-2 and SARS-CoV-1, which was responsible for the 2003 SARS outbreak.

Could Llamas Hold the Key to Fighting COVID-19? - Vimarsana News

Could Llamas Hold the Key to Fighting COVID-19?

WEDNESDAY, June 29, 2022 (HealthDay News) -- Llamas are more than beautiful creatures -- they could also help protect humans from COVID-19 and a large array of similar viruses.

Zymeworks Appoints Dr. Paul Moore as Chief Scientific Officer - Vimarsana News

Zymeworks Appoints Dr. Paul Moore as Chief Scientific Officer

Dr. Moore will lead Zymeworks’ Early Research & Development Group responsible for advancing the Company’s next-generation of multispecific antibody programs and antibody drug... | June 27, 2022